Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) has been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $18.20.

Several research firms have recently issued reports on BWAY. New Street Research reaffirmed a “buy” rating on shares of Brainsway in a research note on Friday, July 24th. LADENBURG THALM/SH SH lifted their target price on shares of Brainsway from $18.00 to $18.80 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Zacks Research lowered shares of Brainsway from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. BTIG Research restated a “buy” rating and issued a $20.00 price target on shares of Brainsway in a research report on Thursday, September 10th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $19.00 price target on shares of Brainsway in a research note on Tuesday, September 8th.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Brainsway during the 1st quarter worth about $40,000. Ballast Advisors LLC acquired a new position in shares of Brainsway in the 1st quarter valued at about $55,000. Bank of America Corp DE acquired a new stake in Brainsway during the first quarter worth approximately $206,000. Royal Bank of Canada increased its position in Brainsway by 84.2% in the 1st quarter. Royal Bank of Canada now owns 15,490 shares of the company’s stock valued at $206,000 after buying an additional 7,080 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Brainsway during the 1st quarter valued at $232,000. 30.11% of the stock is owned by institutional investors.

Brainsway Stock Performance

Shares of BWAY opened at $11.77 on Friday. Brainsway has a 52 week low of $7.14 and a 52 week high of $17.40. The stock has a market capitalization of $473.62 million, a price-to-earnings ratio of 26.75 and a beta of 1.29. The stock has a fifty day moving average of $14.11 and a 200-day moving average of $14.69.

Brainsway (NASDAQ:BWAY) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.04. Brainsway had a return on equity of 12.74% and a net margin of 15.65%. The business had revenue of $17.11 million for the quarter, compared to analyst estimates of $16.54 million. As a group, equities analysts forecast that Brainsway will post 0.33 EPS for the current year.

About Brainsway

BrainsWay Ltd. is a medical technology company that develops and commercializes noninvasive treatments for brain disorders. Its primary technology, Deep Transcranial Magnetic Stimulation (Deep TMS), uses electromagnetic fields to stimulate targeted areas of the brain and is delivered through specialized treatment systems and helmet-like coils.

The company’s Deep TMS platform is used by healthcare providers in the treatment of major depressive disorder, obsessive-compulsive disorder and smoking addiction, subject to applicable regulatory clearances and local treatment guidelines.